Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.56 USD | -5.76% | -1.81% | +62.46% |
05-20 | Enliven Therapeutics Insider Sold Shares Worth $22,877,262, According to a Recent SEC Filing | MT |
05-14 | Enliven Therapeutics Q1 Loss Narrows | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- ELVN Stock
- Revisions Enliven Therapeutics, Inc.